Combination therapy development: emerging I-O therapeutic modalities and predictive technologies

IMMUNO-ONCOLOGY INSIGHTS

Combination therapy development: emerging I-O therapeutic modalities and predictive technologies

November 2022
Combination therapy development: emerging I-O therapeutic modalities and predictive technologies
Download PDF

Expert Insight

Powering antitumor immunity: challenges & promise at the intersection of immunometabolism & cancer immunotherapy

Powering antitumor immunity: challenges & promise at the intersection of immunometabolism & cancer immunotherapy

Maya Lopez-Ichikawa, Lauren Levine
28 November 2022
Read

Interview

A career in cancer vaccines: exploring the promise of B cell epitopes

A career in cancer vaccines: exploring the promise of B cell epitopes

Pravin Kaumaya
21 November 2022
Read

Viewpoint

Customizing T cell biology: armoring approaches to optimize allogeneic CAR-T therapies

Customizing T cell biology: armoring approaches to optimize allogeneic CAR-T therapies

Jakob Dupont
28 November 2022
Read

Webinars

Assessing efficacy and MoA of mono and combo immunotherapies in preclinical humanized models

Assessing efficacy and MoA of mono and combo immunotherapies in preclinical humanized models

K Thiam PhD, E van der Horst PhD, A Surya PhD
18 January 2023
Watch